These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22932290)

  • 1. [Diabetes mellitus and osteoporosis. Predictive candidate markers for fracture risk in diabetic patients].
    Yamamoto M
    Clin Calcium; 2012 Sep; 22(9):1359-65. PubMed ID: 22932290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ratio of Endogenous Secretory Receptor for Advanced Glycation End Products to Pentosidine Predicts Fractures in Men.
    Tamaki J; Kouda K; Fujita Y; Iki M; Yura A; Miura M; Sato Y; Okamoto N; Kurumatani N
    J Clin Endocrinol Metab; 2018 Jan; 103(1):85-94. PubMed ID: 29040721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Yamauchi M; Sugimoto T
    Diabetes Care; 2009 Dec; 32(12):2263-8. PubMed ID: 19752174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Bone metabolic disorders in patients with diabetes mellitus].
    Yamamoto M
    Clin Calcium; 2013 Sep; 23(9):1327-35. PubMed ID: 23999370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control.
    Neumann T; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Sämann A
    Osteoporos Int; 2014 May; 25(5):1527-33. PubMed ID: 24599273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Yamauchi M; Yano S; Sugimoto T
    J Clin Endocrinol Metab; 2008 Mar; 93(3):1013-9. PubMed ID: 18160470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of diabetes and its treatments on skeletal diseases.
    Yan W; Li X
    Front Med; 2013 Mar; 7(1):81-90. PubMed ID: 23377889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Mellitus: Does it Affect Bone?
    Schwartz AV
    Calcif Tissue Int; 2003 Dec; 73(6):515-9. PubMed ID: 14517715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.
    Gohda T; Tanimoto M; Moon JY; Gotoh H; Aoki T; Matsumoto M; Shibata T; Ohsawa I; Funabiki K; Tomino Y
    Diabetes Res Clin Pract; 2008 Aug; 81(2):196-201. PubMed ID: 18550199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Roles of collagen enzymatic and advanced glycation end products associated crosslinking as a determinant of bone quality].
    Saito M; Marumo K
    Nihon Rinsho; 2011 Jul; 69(7):1189-97. PubMed ID: 21774356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentosidine and increased fracture risk in older adults with type 2 diabetes.
    Schwartz AV; Garnero P; Hillier TA; Sellmeyer DE; Strotmeyer ES; Feingold KR; Resnick HE; Tylavsky FA; Black DM; Cummings SR; Harris TB; Bauer DC;
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2380-6. PubMed ID: 19383780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonenzymatic cross-linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients.
    Mitome J; Yamamoto H; Saito M; Yokoyama K; Marumo K; Hosoya T
    Calcif Tissue Int; 2011 Jun; 88(6):521-9. PubMed ID: 21499867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone metabolism and fracture risk in type 2 diabetes mellitus [Review].
    Yamaguchi T; Sugimoto T
    Endocr J; 2011; 58(8):613-24. PubMed ID: 21778617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength.
    Yamamoto M
    Endocr J; 2015; 62(4):299-308. PubMed ID: 25797364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus a risk for osteoporosis?
    Leidig-Bruckner G; Ziegler R
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S493-514. PubMed ID: 11460594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone quality markers: pentosidine, homocysteine, and MTHFR polymorphism].
    Saito M
    Rinsho Byori; 2009 Sep; 57(9):876-83. PubMed ID: 19860214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of carboxymethyl-lysine (CML) in human cortical bone.
    Thomas CJ; Cleland TP; Sroga GE; Vashishth D
    Bone; 2018 May; 110():128-133. PubMed ID: 29408699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the compromised biomechanical performance of type 2 diabetes- and Roux-en-Y gastric bypass bone by linking mechanical-structural and physico-chemical properties.
    Marin C; Papantonakis G; Sels K; van Lenthe GH; Falgayrac G; Vangoitsenhoven R; Van der Schueren B; Penel G; Luyten F; Vandamme K; Kerckhofs G
    Sci Rep; 2018 Apr; 8(1):5881. PubMed ID: 29651097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical markers of bone turnover. New aspect. Bone collagen metabolism: new biological markers for estimation of bone quality].
    Saito M
    Clin Calcium; 2009 Aug; 19(8):1110-7. PubMed ID: 19638694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
    Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
    Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.